Ridgecrest Wealth Partners, LLC Eli Lilly & CO Transaction History
Ridgecrest Wealth Partners, LLC
- $167 Million
- Q1 2024
A detailed history of Ridgecrest Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ridgecrest Wealth Partners, LLC holds 856 shares of LLY stock, worth $804,451. This represents 0.4% of its overall portfolio holdings.
Number of Shares
856
Previous 856
-0.0%
Holding current value
$804,451
Previous $498,000
33.53%
% of portfolio
0.4%
Previous 0.33%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
3,728Shares Held
738MCall Options Held
7.09MPut Options Held
7.24M-
Lilly Endowment Inc Indianapolis, IN98.9MShares$92.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$68.4 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$61.3 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$48.3 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$32.2 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $893B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...